CF PharmTech, Inc.

HK$5.16As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2652Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM (82.97%)
Mkt cap HK$2.205B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.65
28.91%
(13.28%)
Hold 12|6|1|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.11
0.12
0.13
10.10%
2.24%
1.44%
10.44%
Revenue¥M
119.2
125.2
130.7
138.0
5.19%
4.50%
6.22%
15.38%
Peers (US$281.3M)
Cap (US$)
PE
275.7M
29.33x
Capital
TTM
5Y
10Y
Leveragex
1.530
0.115
0.091
EBIT/Intx
1.133
0.450
0.393
Own earn%
74.62
(61.23)
(79.48)
Sh yield%
30.52
53.32
51.28
Owners
Insiders/Inst%
3.90
64.35
Short interest%
0.75
SBC / revenue%
1.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
24–31
$1 testx
0.0
Incr. ROIC%
60